(1)
Preclinical Efficacy and Cellular Mechanisms of a Polyherbal Formulation in Doxorubicin Nephrotoxicity: PRECLINICAL SAFETY AND EFFICACY OF A POLYHERBAL FORMULATION. IJTK 2025, 24 (1), 33-41. https://doi.org/10.56042/ijtk.v24i1.5664.